Yujin Jin - Publications

Innate immune surveillance and nucleic acid sensing: Gatekeepers of inflammatory cell death in respiratory infectious diseases.

Journal: Pharmacological research

Published: April 08, 2026

Dual Targeting of Tau Kinases and Autophagy by Abemaciclib Independent of CDK4/6 Inhibition.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 13, 2025

Sialyllactose Alleviates Streptozotocin-Induced Diabetes through Anti-Inflammatory and Metabolic Modulation.

Journal: Biomolecules & therapeutics

Published: April 30, 2025

Mechanistic insights and emerging therapeutic strategies targeting endothelial dysfunction in cardiovascular diseases.

Journal: Archives of pharmacal research

Published: February 19, 2025

Potential effects of a human milk oligosaccharide 6'-sialyllactose on angiotensin II-induced aortic aneurysm via p90RSK/TGF-β/SMAD2 signaling pathway.

Journal: Archives of pharmacal research

Published: July 07, 2024

Protective effect of 6'-Sialyllactose on LPS-induced macrophage inflammation via regulating Nrf2-mediated oxidative stress and inflammatory signaling pathways.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Published: March 19, 2024

3'-Sialyllactose protects against LPS-induced endothelial dysfunction by inhibiting superoxide-mediated ERK1/2/STAT1 activation and HMGB1/RAGE axis.

Journal: Life sciences

Published: October 19, 2023

Human milk oligosaccharides 3'-sialyllactose and 6'-sialyllactose attenuate LPS-induced lung injury by inhibiting STAT1 and NF-κB signaling pathways.

Journal: Archives of pharmacal research

Published: June 16, 2023

Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Published: April 20, 2023

Ginsenoside Rh1 ameliorates the asthma and allergic inflammation via inhibiting Akt, MAPK, and NF-κB signaling pathways in vitro and in vivo.

Journal: Life sciences

Published: January 19, 2023

6'-Sialylactose abolished lipopolysaccharide-induced inflammation and hyper-permeability in endothelial cells.

Journal: Archives of pharmacal research

Published: July 25, 2022

Ginsenoside Rh1 protects human endothelial cells against lipopolysaccharide-induced inflammatory injury through inhibiting TLR2/4-mediated STAT3, NF-κB, and ER stress signaling pathways.

Journal: Life sciences

Published: May 23, 2022